For decades, the probiotic industry fixed its gaze on the gut. BLIS Technologies was looking somewhere else.
Twenty-five years ago, BLIS identified and patented Streptococcus salivarius strains — probiotics designed specifically for the mouth and throat, at a time when oral microbiome research barely registered as a category.
That early conviction is now becoming the industry’s next major conversation. As evidence connects oral health to systemic outcomes — cardiovascular, respiratory, immune — the question isn’t whether oral probiotics matter. It’s who built the science to prove it.
This short film tells that founding story. Where the research began, what it took to build a category from scratch, and why what happens in the mouth may be the most underestimated frontier in human health.
Watch the film
